围术期输血与非小细胞肺癌切除术后复发及生存的剂量依赖关系
该研究纳入2000年至2016年在本机构接受解剖性肺切除的5709例非小细胞肺癌患者,排除IIIB-IV期、不完全切除、组织学亚型不明确和非解剖性楔形切除者。约10%患者接受围术期输血,中位随访7.46年。单单位输血与未输血相比,总生存、无病生存和累积复发率均无差异(P > .05);但随输血单位数增加,总生存(总体P < .001)、无病生存(总体P < .001)和复发(总体P = .010)均呈剂量依赖性恶化。
要点
- 单单位围术期输血未显著影响NSCLC肺切除患者的总生存、无病生存或复发。
- 输血单位数增加与总生存、无病生存和复发呈剂量依赖性恶化(总体P分别<.001、<.001、.010)。
- 提示避免或最小化围术期输血可能改善肺切除术后长期生存。
核心结论
- 单单位围术期输血不影响NSCLC肺切除患者生存,但更多单位输血与长期结局剂量依赖性下降相关。
研究设计与样本
- 回顾性队列研究,纳入2000年1月1日至2016年6月30日在本机构接受解剖性肺切除的5709例NSCLC患者。
- 排除IIIB-IV期疾病、不完全切除、组织学亚型不明确和非解剖性楔形切除。
- 单单位对比未输血分析采用倾向评分加权并纳入Cox模型;多单位分析采用多变量Cox模型。
主要发现
- 约10%患者接受围术期输血,中位随访7.46年(25th-75th百分位3.98-11.8)。
- 未输血与单单位输血患者的总生存、无病生存和累积复发率无差异(P > .05)。
- 随输血单位数增加,总生存(总体P < .001)、无病生存(总体P < .001)和复发(总体P = .010)均显著恶化。
临床怎么用
- 肺切除围术期应避免或最小化输血,尤其避免多单位输血,以可能改善长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Perioperative blood transfusions have been implicated in decreased overall survival (OS) and disease-free survival (DFS) after resection for non-small cell lung cancer (NSCLC). We investigated the effects of single- and multiple-unit blood transfusions on OS, DFS, and recurrence after anatomic pulmonary resection. METHODS: From January 1, 2000, to June 30, 2016, 5709 consecutive patients underwent pulmonary resection for NSCLC at our institution. Exclusion criteria were stage IIIB-IV disease, incomplete resections, ill-defined histologic subtypes, and nonanatomic wedge resections. For the 0 versus single-unit analysis, propensity scores were calculated from a logistic regression model that predicted the probability of patients receiving a single-unit transfusion. The resulting matching weights were incorporated into Cox models for OS, DFS, and cumulative incidence of recurrence, to compare no versus single-unit blood transfusion. We determined whether increasing numbers of blood transfusions influenced survival or recurrence using multivariable Cox models. RESULTS: Approximately 10% of patients received perioperative blood transfusion (median follow-up, 7.46 years [25th-75th percentile, 3.98-11.8]). There was no difference in OS, DFS, or cumulative incidence of recurrence between patients receiving no transfusion and those receiving single-unit transfusion (P > .05). However, a dose-response relationship was observed, demonstrating worse OS (overall P < .001), DFS (overall P < .001), and recurrence (overall P = .010) with increasing units of blood transfused. CONCLUSIONS: Although a single-unit blood transfusion did not affect survival in patients undergoing resection for NSCLC, greater unit perioperative blood transfusions were associated with significantly decreased long-term outcomes in a dose-dependent manner, suggesting avoidance or minimization of transfusions could improve long-term survival after lung resection.
引用
- Latif MJ, Tan KS, Molena D, et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019. PMID: 30902468. doi:10.1016/j.jtcvs.2018.12.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。